IP Library Assignment 042256/0971
Patent Assignment
Reel/Frame 042256/0971

Confirmatory License

Recorded: 2017-04-14 Pages: 2
Assignor
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Use of Inhibitory Oligonucleotides to Treat Autoimmune Disease
Patent: 8,729,039 →
Application: 12/862,429 →
Publication: US 2011/0182927
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 29, 2010
From: RAZ, EYAL
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 025063/0651 →
Assignment of Assignor's Interest Sep 29, 2010
From: ROMAN, MARK
To: DYNAVAX TECHNOLOGIES CORP.
Reel/Frame 025063/0709 →
Confirmatory License Aug 4, 2011
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026699/0518 →
Confirmatory License Mar 17, 2020
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052136/0160 →